Novartis drug Gilenya shows long-term efficacy and safety
New long-term data for Gilenya (fingolimod), the only oral therapy approved to treat people with relapsing forms of multiple…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Made-In-Singapore H5N1 bird flu diagnostic kit to detect all known strains of virus with single test
Licence agreement signed between local SME, AITbiotech and A*STAR to market the test kit will directly benefit public healthcare…
Unichem Laboratories: Steering through change
Unichem Laboratories' story so far reflects the inherent strengths of Indian pharma: enterprise and hard work. How will policy…
‘Successful marketing is impossible without relevant branding’
Like other industries, branding is important for the pharmaceutical industry as well. Alpana Parida, President, DY Works speaks…
Quintiles releases New Health Report 2012
The report offers perspective and insight into key topics to help the healthcare industry’s key stakeholders understand the…
Mahindra SSG makes it to finals of global security awards
Mahindra SSG's Project Firewall, implemented at Dr Reddy’s Laboratories, was among the eight finalists in the Security…
GoI bans use, import of blood test kits for TB
WHO had found that such kits give misleading results and could result in more harm than good
LifeSciences R&D: India can leverage its unique advantage to play a critical role
Bart Janssens, Partner & Director BCG and Rahul Guha, Principal, BCG about the areas of unique advantage for India in…
Threat to American dream of Indian biopharma
The Indian biopharma industry is concerned that if Obamacare is repealed due to the individual mandate issue, their plans for the…
Nurturing India’s small biotech
With India's DBT commiting 30 per cent of its budget to PPPs, will these fund an ecosystem for small and medium sized companies…